Fewer people in most key groups are taking up the latest Covid vaccine compared to earlier phases.
There are still 15,100 people with a weakened immune system who have not taken up an autumn booster in WalesThe total now stands at 1,023,594 boosters given out, according to the latest Public Health Wales figures.
"But we are not fully immune to the virus and we must keep our defences up," she said. "Covid-19 and flu remain a threat, especially to older people and people with other health conditions." But only a third of two and three-year-olds have had a flu vaccine so far, compared to more than 38% at the same point in 2021.
Dr Sir Frank Atherton, chief medical officer for Wales, urged people to take advantage of walk-in appointments - and for those who had not received an appointment to check with their health board.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Defense bill could roll back Covid vaccine policy, top Dem saysThousands of troops have been kicked out for refusing the Covid vaccine. Undoing the 2021 policy would be a win for Republicans who argue it's exacerbating a recruiting and retention crisis.
Les mer »
China reports 2 new COVID deaths as some restrictions easedChina today reported two additional deaths from COVID-19 as some cities move cautiously to ease anti-pandemic restrictions amid increasingly vocal public frustration over the measures.
Les mer »
As COVID cases, other viruses continue to rise, SoCal inches closer to a mask mandateExperts say the combination of COVID, the flu, and RSV is putting an enormous strain on hospitals.
Les mer »
Covid hospitalizations rising post-Thanksgiving after an autumn lullA post-Thanksgiving uptick in covid-19 patients at U.S. hospitals is arriving even as health systems contend with waves of feverish, coughing people stricken with RSV and influenza infections.
Les mer »
COVID-19 Monoclonal Antibody Treatments No Longer EffectiveThe FDA has said that bebtelovimab, a monoclonal antibody drug given through a vein, is no longer authorized because it is not effective against the leading strains of COVID-19. This drug was the last remaining monoclonal antibody treatment of six that had been authorized for emergency use during the pandemic.
Les mer »